1. Introduction {#sec1}
===============

Quantitative real-time PCR (qPCR) is commonly used in analyzing gene expression levels owing to its credible precision and high-throughput competence \[[@B1], [@B2]\]. However, quantitative analysis of gene expressions is unavoidably affected by several factors such as sample amount, cell activity, RNA integrity, and cDNA quality \[[@B3]--[@B5]\]. Hence, in order to avoid quantitative errors and obtain a reliable experimental result, one or several reference genes should be applied as a suitable endogenous control for quantitative measurement of gene expression. Some literature indicated that at least three reference genes were needed to normalize the analysis of qPCR \[[@B6], [@B7]\]. In addition, numerous reports affirmed that the stability of reference genes might change based on various experimental designs and samples \[[@B8], [@B9]\]. Hence, a stable reference gene, which ensures the stability in various experimental conditions, should be identified.

Traditionally, *GAPDH* and *ACTB* are most frequently used for normalization; however, they have been demonstrated unsuitable for internal control because their stability varies in different experiments and samples \[[@B10]--[@B12]\]. For instance, in Li et al.\'s \[[@B13]\] study, the mean Cp value of *GAPDH* was 23.88 in H2O2 treated human umbilical vein endothelial cells (HUVEC), while in cytokines treated HUVEC, the mean Cp values of *GAPDH* was distinctly below 20 \[[@B14]\]. Undoubtedly, the varied expressions of reference genes lead to the inaccuracy of results. Fortunately, an increasing number of researches have focused on selecting and identifying suitable reference genes of humans \[[@B15]\], plant \[[@B16]\], cell line \[[@B17]\], algae \[[@B18]\], animal \[[@B19]\], and bacteria \[[@B20]\]. However, a systematic research about the validation of suitable reference genes for liver cell (HepG2 and L02) injured models has not been reported.

HepG2 is an immortalized human hepatoma cell line, and L02 is an immortalized hepatocyte cell line \[[@B21], [@B22]\]. Additionally, HepG2 and L02 are widely accepted model systems for investigating hepatotoxicity, intracellular trafficking, and drug targeting in vitro \[[@B23]--[@B25]\]. Owing to the stability of reference genes varied with drug-treatments and differed in different cell lines \[[@B26]\]. Hence, in this study, we chose four liver cell injured models commonly used in pharmacology and toxicology: ethanol (EtOH) \[[@B27]\], hydrogen peroxide (H~2~O~2~) \[[@B28]\], acetaminophen (APAP) \[[@B29]\], and carbon tetrachloride (CCl~4~) \[[@B30]\], which represented alcoholic liver injury (EtOH), hepatic oxidative stress (H~2~O~2~), drug liver injury (APAP), and acute liver damage (CCl~4~), respectively, to find the most appropriate reference genes in different cell injured models of HepG2 and L02.

In this study, ten candidate reference genes, *ACTB, B2M, GAPDH, TUBB2a*, hypoxanthine phosphoribosyltransferase 1 (*HPRT1*), succinate dehydrogenase complex flavoprotein subunit A (*SDHA*), TBP, YWHAZ, cytochrome c isoform 1 (*CYC1*), and glucuronidase beta (*GUSB*), were selected to investigate the most stable reference genes for normalization in liver cell injured models. To evaluate the stability of candidate reference genes comprehensively, four types of experimental treatments (EtOH, H~2~O~2~, APAP, and CCl~4~) were investigated in two cell types (HepG2 and L02) *in vitro*. In addition, in order to analyze the correlation between different concentrations of drug treatment and expression levels of reference genes, we selected three groups of different concentrations (low dose group, middle dose group, and high dose group) for each treatment. All concentrations were chosen based on previous studies \[[@B31]--[@B36]\] which had performed a cell viability assay proving varying degrees cytotoxicity. To analyze the original data, three statistical algorithms named, geNorm \[[@B37]\], NormFinder \[[@B38]\], and Bestkeeper \[[@B39]\] were used based on the manufacturers\' procedures. The calculation results of three kinds of software showed that *TBP* and *TUBB2a* were the most stable ones among all treatments. Moreover, geNorm was also used to calculate the optimal number of reference genes needed for normalization, and the results showed that it was sufficient for accuracy normalization to choose two reference genes in most groups. To our knowledge, this is the first study about the selection of the best reference genes in liver cell injured models, which would provide a proper choice of reference genes and guarantee a dependable result in liver cell injured model research.

2. Materials and Methods {#sec2}
========================

2.1. Reagents {#sec2.1}
-------------

The ethanol (EtOH, 99.5% pure), hydrogen peroxide (H2O2, 30.0% pure), acetaminophen (APAP, 99.5% pure), and carbon tetrachloride (CCl~4~, 99.5% pure) were purchased from Aladdin Biochemical Technology Co., Ltd (Shanghai, China); Penicillin and streptomycin were obtained from Beyotime Institute of Biotechnology (Shanghai, China); Trypsin-EDTA Solution was purchased from Sangon Biotech (Shanghai, China).

2.2. Cell Culture and Treatment {#sec2.2}
-------------------------------

The hepatoma carcinoma cells (HepG2) were obtained from the American Type Culture Collection (HB-8065), and the human hepatocyte cells were purchased from the Cell Bank of Type Culture Collection of the Chinese Academy of Sciences. Cells were grown in Dulbecco\'s Modified Eagle Medium (DMEM, Gibco), containing 100 U/ml penicillin-streptomycin and 10% fetal bovine serum (FBS, Bioind) under standard conditions (37°C and 5% CO~2~). The cells were grown to 80% confluence and then passaged using Trypsin-EDTA Solution (0.25% Trypsin, 0.02% EDTA). All cells were divided into four groups for treatments: (a) control group; (b) low dose group; (c) middle dose group; (d) high dose group. For HepG2, cells were treated with four different treatments, including ethanol (100 mM, 200 mM, 400 mM), H~2~O~2~ (200 *μ*M, 400 *μ*M, 800 *μ*M), APAP (2.5 mM, 5 mM, 10 mM), and CCl~4~ (0.1%, 0.2%, 0.4%). For L02, cells were treated with four different treatments, including ethanol (100 mM, 200 mM, 400 mM), H~2~O~2~ (100 *μ*M, 200 *μ*M, 400 *μ*M), APAP (2.5 mM, 5 mM, 10 mM), and CCl~4~ (0.05%, 0.1%, 0.2%). The CCl~4~ were dissolved into 0.25% DMSO and then were added to the serum-free DMEM; the ethanol, H~2~O~2~, and APAP were dissolved into serum-free DMEM directly. Cells were seeded in six-well plates before being subjected to treatments. For all groups, cells were incubated in the presence or absence of various treatments and different concentrations for 24 h.

2.3. Screening of Candidate Reference Genes and Primer Design {#sec2.3}
-------------------------------------------------------------

According to previous studies \[[@B9], [@B40]\], a total of ten candidate reference genes (*ACTB*, *B2M*, *GAPDH*, *TUBB2a*, *HPRT1*, *SDHA*, *TBP*, *YWHAZ*, *CYC1*, and *GUSB*) were selected to ascertain the best reference genes of HepG2 and L02 in liver cell injured conditions. The nucleotide sequences were downloaded, using Primer 5 to design primers. Full gene names and accession numbers, as well as primer length and intron-spanning primers, were listed in [Table 1](#tab1){ref-type="table"}. The data of qPCR were repeated three times of biological and technical replicates.

2.4. Total RNA, DNA Extraction and cDNA Synthesis {#sec2.4}
-------------------------------------------------

Total RNA was extracted from HepG2 and L02 and purified using the RNAiso Plus total RNA kit (TransGen Biotech, Dalian, China) according to the manufacturer\'s instruction. And then, DNase I (Takara, Dalian, China) was added to the sample to eliminate DNA contamination for RNA purity. The purity of the total RNA was assessed by measuring the absorbance ration at 260/280 nm of the samples. In addition, the quality of the RNA was confirmed by agarose gel electrophoresis. Purified RNA was reverse transcribed immediately after extraction. For qPCR experiments, HiScript® Q RT SuperMix for qPCR Kit (Vazyme, Nanjing, China) and a quantity of 1 *μ*g total RNA were added into a 20 *μ*l reaction volume to synthesize cDNA.

2.5. Quantitative Real-Time PCR {#sec2.5}
-------------------------------

The sample reaction was run in 96-well plate. Real-time quantitative PCR with AceQ qPCR SYBR Green Master Mix (Vazyme, Nangjing, China) was performed at LightCycler 480 (Roche Molecular Biochemicals, Mannheim, Germany). Each reaction system was 20 *μ*l, respectively. AceQ qPCR SYBR Green Master Mix 10 *μ*l, forward and reverse primers were 0.4 *μ*M each, template cDNA 2 *μ*l, and added ddH~2~O to the final volume of 20 *μ*l. Each sample was repeated 3 times. The optimizing reaction conditions of real-time quantitative PCR as follows: 1 cycle of 95°C for 5 min, 40 cycles of 95°C for 10 sec, and then 60°C for 30 sec.

2.6. Analysis of Reference Genes Stability {#sec2.6}
------------------------------------------

In order to evaluate the stability of ten selected reference genes, three reference gene validation programs (geNorm, NormFinder, and BestKeeper) were used under the manufacture\'s instruction. NormFinder was applied to calculate the stability value (*M*) for finding the steadiest candidate genes. For geNorm, the calculation could determine the optimal number of reference genes and, similar to geNorm, evaluate the stability of candidate genes. BestKeeper was based on the coefficient of variance (CV) and the standard deviation (SD) of the Cp values to assess the steadiness of reference genes. Three biological and technical repeats were used for different experimental conditions.

3. Results {#sec3}
==========

3.1. Verification of the Primers Specificity {#sec3.1}
--------------------------------------------

We used PCR to identify the specificity of the designed primers by agarose gel electrophoresis, as [S2](#supplementary-material-1){ref-type="supplementary-material"} and [S3](#supplementary-material-1){ref-type="supplementary-material"} Figs shows, the single band and peak of a melting curve indicated primers possessed the good specificity.

3.2. Evaluating Expression of the Reference Gene {#sec3.2}
------------------------------------------------

The most suitable reference genes would have stable expression levels in various treatments and concentrations. And the Cp value of ten candidate reference genes underwent diver treatments were listed in [Figure 1](#fig1){ref-type="fig"}, ranging from 14.7 to 34.49 (HepG2 14.7 to 34.49, L02 14.85 to 34.48), suggesting that they have a noticeable variance in expression level. Particularly, most of the Cp values were in a range of 20 to 27. *ACTB*, *B2M*, *GAPDH*, *HPRT1*, and *YWHAZ* expressed lower Cp value around 20, while the rest of the genes showed that higher Cp value was greater than 25, especially the *GUSB*, which had the highest mean Cp values (HepG2 30.02 ± 1.49, L02 30.99 ± 1.66). Notably, *ACTB* showed the minimal change of Cp values from 18.44 to 24.90 under different treatments in HepG2, and meanwhile, the Cp values of *HPRT1* from 21.46 to 27.02 showed the low variation in L02, suggesting that the two genes might have a constant expression under various treatments and could be a suitable reference gene. In short, Cp values, combined with box-plot, presented the expression of the reference genes, and as well provided us a general understanding of gene stability.

3.3. Expression Stability of Candidate Reference Genes {#sec3.3}
------------------------------------------------------

The data obtained from different treatments (wild-type APAP, CCl~4~, ethanol, and H~2~O~2~) and each reference gene were analyzed with three Excel-based programs (geNorm, NormFinder, and BestKeeper) for further evaluation on the stability of putative reference genes.

3.4. geNorm Analysis {#sec3.4}
--------------------

To ascertain the stability of candidate reference genes, geNorm was applied to evaluate the expression stability measurement (*M*) value by Cp values of each gene in groups. According to the analysis of geNorm, genes with the highest *M* values were considered as the least stable ones and the lowest the most. As shown in [Figure 2](#fig2){ref-type="fig"} and [S1](#supplementary-material-1){ref-type="supplementary-material"} Figure, different reference genes had different *M* values in different treatments. For instance, in the L02 groups, *TBP* with the *M* value of 0.51 in 400 *μ*M H~2~O~2~ treatment would be the steadiest reference genes, while the *GUSB* was more than twice *TBP*, with *M* value was 1.37 in the same treatment. More interestingly, even the same reference gene had different expressions in different treatments. In the HepG2 groups, the gene with the lowest *M* values in 10 mM APAP treatment was *HPRT1*, which owned the highest *M* values in 200 *μ*M H~2~O~2~ treatment, meaning that *HPRT1* was the most stable genes in 10 mM APAP treatment and the least stable ones in 200 *μ*M H~2~O~2~ treatment.

3.5. NormFinder Analysis {#sec3.5}
------------------------

NormFinder was used to evaluate the optimal gene for normalization in each experiment. The raw Cp values obtained from qPCR were firstly log-transformed and used as the input value for the NormFinder, and then used to analyze the expression stability according to the similarity of the expression profiles of candidate genes. Genes with lower values that were close to zero were regarded as the best candidate ones. As shown in [Table 2](#tab2){ref-type="table"} and [S1](#supplementary-material-1){ref-type="supplementary-material"} Table, the rank of *M* values was increasing from top to bottom of the table, whereas genes on the top of the table were the most stable reference genes. Therefore, the most stable candidate genes could be easily found from the table. In the HepG2 group, *CYC1* (7 times to be the top 3 candidate genes in 13 treatments) and *HPRT1* (8 times to be the top 3 in 13 treatments) were considered as the most stable reference genes; the results were similar to that of geNorm analysis. Nevertheless, in the L02 group, the results of geNorm and NormFinder analysis seemed to be different. For instance, in the NormFinder analysis, *TUBB2a* (9 times to be the top 3 in all treatments) was the steadiest ones, while *GAPDH*, the most stable genes in the geNorm analysis, appeared only once to be the top 3 of all treatments. Hence, the third analysis method should be used.

3.6. BestKeeper Analysis {#sec3.6}
------------------------

BestKeeper was an Excel-based tool used to analyze the expression stability of the candidate reference gene. The standard deviation (SD) and coefficient of variation (CV) were calculated by BestKeeper to assess the stability of candidate reference genes in each group. Genes with the lowest SD and CV would be the most stable reference ones. As shown in [Table 3](#tab3){ref-type="table"} and [S2](#supplementary-material-1){ref-type="supplementary-material"} Table, the (CV ± SD) values of ten candidate reference genes progressively increased from top to bottom of tables, showing their decreasingly stability. As an example, TBP was listed on the top of [Table 3](#tab3){ref-type="table"}, with a lower (CV ± SD) value of (0.85 ± 0.24), representing the most stable genes in 800 *μ*M H~2~O~2~ induced oxidative stress in HepG2, and meanwhile, *GUSB*, having a (CV ± SD) value of (5.42 ± 1.62), was listed at the bottom of the table. In HepG2 groups, some reference genes, namely, *TBP*, *CYC1*, and *TUBB2a*, might be the best suitable genes for the reason that they were listed on top 3 of the rank in majority treatments. Similarly, *CYC1* and *TBP* occupied most of the top 3 in the table, suggesting that the two candidate genes would be the steadiest genes in L02 treatments.

3.7. Optimal Numbers of Reference Genes for Normalization {#sec3.7}
---------------------------------------------------------

The minimal numbers of reference genes for accurate normalization could also be determined by geNorm, according to the calculation of pairwise variation (variation coefficient, V) between the normalization factors (NF) in various treatment sets using Vn/*n* + 1 \< 0.15 as a criterion cut-off value \[[@B37]\]. Based on this rule, the calculation was listed in [Figure 3](#fig3){ref-type="fig"}. As we can see, there were enough to choose two or three reference genes in most treatments of HepG2 and L02 for normalization. Moreover, 10 mM APAP treatment in HepG2, 200 mM EtOH, and 400 mM EtOH in L02, respectively, required four, five, and nine reference genes for normalization.

4. Discussion {#sec4}
=============

Quantitative real-time PCR is one of the most accurate and commonly used techniques for analysis of gene transcript levels. Selection of suitable reference gene is indispensable to guarantee the accuracy and consistency of the data and minimize the experimental errors. To confirm the precise expression analysis of putative genes, numerous steady reference genes have been verified in different experimental designs \[[@B41], [@B42]\]. Hence, the purpose of this study was to investigate the expression stability of ten candidate reference genes (*ACTB*, *B2M*, *GAPDH*, *TUBB2a*, *HPRT1*, *SDHA*, *TBP*, *YWHAZ*, *CYC1*, *GUSB*) in two in-vitro cell types, namely, HepG2 cells and L02 cells, and determine the optimal candidate genes under the treatment of alcoholic liver injury (EtOH), hepatic oxidative stress (H~2~O~2~), drug liver injury (APAP), and acute liver damage (CCl~4~). After that, raw data was input and calculated in three Excel-based programs: geNorm, NormFinder, and BestKeeper.

The data from qPCR run of ten candidate genes were listed in [Figure 1](#fig1){ref-type="fig"}, where the expression level and mean Cp values of the candidate genes ranging from 14.7 to 34.49 (HepG2 14.7 to 34.49, L02 14.85 to 34.48) could be easily seen. However, the scope of the Cp values of some selected genes inconsistent with the previous study \[[@B43], [@B44]\] might be a result of liver damage treatments. Based on the fact that the genes with the highest expression levels owned minimal Cp values, *GAPDH* with the lowest mean Cp values of 17.47 in HepG2 and 17.25 in L02 means that the *GAPDH* was abundantly distributed in the two cell types. Considering that a wide distribution range tends to be low stability and moreover, Cp values with low variation would be more suitable for reference gene selection. The variation of Cp values suggested that *ACTB* and *HPRT1* were the best reference genes in HepG2 and L02, while *HPRT1* and *YWHAZ* were the least ones. The verification above was a little different from the calculation of the three Excel-based programs. For instance, the Cp values of *ACTB* and *HPRT1* might not fluctuate significantly, but in the calculations of the three kinds of software, the two genes appeared at the bottom of ranking frequently, which reflected more instability. Accordingly, more calculation results needed to be combined.

Furthermore, some literature reported that the expression level of reference genes would change under different concentration treatments \[[@B26], [@B45]\]. Hence, we investigated the stability of the reference genes in the same treatment of different concentrations with the results of three software calculations. Since the results of three software varied based on different algorithms, we selected the top five (six in some groups) reference genes for each calculation to evaluate them comprehensively. We identified the top five genes under three concentrations, and then found that genes were common in geNorm, NormFinder, and Bestkeeper. For instance, in CCl~4~ of three concentrations treated L02 cells, *GUSB*, *TUBB2a*, and *TBP* commonly appeared to be the top five of Bestkeeper calculation results, while *SDHA*, *GAPDH*, and *TUBB2a* of geNorm and *SDHA*, *TBP*, and *TUBB2a* of NormFinder, respectively. Apparently, *TUBB2a* appeared to be one of the top five of each calculation. Hence, we recommended *TUBB2a* as the most stable reference genes in CCl~4~ treated L02 cells. Likewise, in L02 cells, *TBP* was considered as the most stable genes in EtOH, H~2~O~2~, and APAP treatments, and *TUBB2a* was the steadiest in CCl~4~ treatments. In HepG2 cells, we suggested *TBP* being the most stable reference genes in EtOH and H~2~O~2~ treatments, and *GUSB* and *CYC1* in APAP and CCl~4~ treatments, respectively. In the same way, we evaluated the least stable reference genes in each group. On the whole, *ACTB*, *GAPDH*, *YWHAZ*, and *B2M* always ranked the last, meaning that they were considered as the least stable. Hence, we did not recommend *ACTB*, *GAPDH*, *YWHAZ*, or *B2M* as internal control for normalization. However, in Bridget\'s study \[[@B44]\], they identified *GAPDH* as the most stable reference genes in APAP treated HepG2, opposite to our research, which was mainly because they evaluated the stability only using geNorm, which might lead to inaccurate results.

Based on the analysis above, we found the best suitable reference genes in different treatments. Nevertheless, how many reference genes were required to be chosen for optimal data normalization required further investigation. Hence, we chose the geNorm software, which could calculate the optimal number of reference genes in a qPCR experiment to solve these problems. According to the handbook \[[@B37]\], the V score of 0.15 as a criterion value was recommended, and an additional gene was included until (Vn/Vn + 1) was lower than 0.15. In this study, the results showed that the majority of pairwise *V* values were lower than 0.15 after a total of 26 treated groups. and the calculation was shown in [Figure 3](#fig3){ref-type="fig"}, among which 23 out of 26 groups with a low *V* \< 0.15, signifying the inclusion of additional reference genes was unnecessary in those 23 groups. Hence, two or three reference genes would suffice for reliable normalization in these groups above. Unfortunately, not all groups had a suitable *V* value of lower than 0.15. For instance, in the 400 mM EtOH treated L02 group, all of pairwise *V* values were greater than 0.15. Vandesompele et al. recommended that it was a waste of resources to quantify more genes than necessary, and hence, the *V* value (V6/7 and V9/10 values were close to 0.15) indicated that six reference genes should be a good choice for normalization in 400 mM treated L02 group.

5. Conclusion {#sec5}
=============

In this study, 10 candidate genes were selected and evaluated in two types of liver cells (HepG2 and L02) for four types of liver cell injured treatments using the three different algorithms, namely, BestKeeper, geNorm, and NormFinder. To the best of our knowledge, this was the first systematic selection of reference genes in the liver cell injured model and laid the basis for further research in HepG2 and L02. Based on the analysis, we identified the best reference genes of HepG2 and L02 under the treatments of EtOH, H~2~O~2~, APAP, and CCl~4~. The results of gene expression revealed that *TBP* and *TUBB2a* were the most stable reference genes for normalization in different treatments. On one hand, in the HepG2, the most stable reference genes of EtOH and H~2~O~2~ treatments were *TBP*, while *GUSB* and *CYC1* were, respectively, the most suitable reference genes of APAP and CCl~4~ treatments. In the L02, *TBP* was identified as the most stable reference genes of EtOH, H~2~O~2~, and APAP treatments, while *TUBB2a* was the steadiest reference genes of CCl~4~ treatment. On the other hand, *ACTB*, *GAPDH*, *YWHAZ*, and *B2M* were the least stable reference genes in EtOH, H~2~O~2~, APAP, and CCl~4~ treated HepG2 and L02. In short, our study provided a credible selection of reference gene in HepG2 and L02 injured models.
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###### 

S1 Figure: expression stability of the housekeeping genes in L02 evaluated by geNorm *M* values represents the average expression stability. From left to right, the value of *M* decreased in turn, indicating the stability gradually increased. Smaller *M* value means higher stability. The control group, ethanol, hydrogen peroxide, acetaminophen, and carbon tetrachloride were abbreviated to WT, EtOH, H2O2, APAP, and CCl4, respectively. S2 Figure: agarose gel (1%) electrophoresis of the ten candidate housekeeping genes. 1-10 represent ACTB, B2M, GAPDH, TUBB2a, HPRT1, SDHA, TBP, YWHAZ, CYC1, and GUSB, respectively. S3 Figure: melt curves of the ten candidate housekeeping genes. S1 Table: expression stability values of ten candidate housekeeping genes in L02 analyzed by NormFinder. S2 Table: expression stability values of the housekeeping genes calculated by BestKeeper in L02.

###### 

Click here for additional data file.

![Expression levels of ten reference genes (*ACTB*, *B2M*, *GAPDH*, *TUBB2a*, *HPRT1*, *SDHA*, *TBP*, *YWHAZ*, *CYC1*, *GUSB*) in HepG2 (a) and L02 (b). Squares in the middle of the box represent the mean values, horizontal lines in the box represent the median, and whiskers represent the highest and lowest values.](BMRI2020-8926120.001){#fig1}

![Expression stability of the reference genes in HepG2 evaluated by geNorm *M* values represents the average expression stability. From left to right, the value of *M* decreased in turn, indicating the stability gradually increased. Smaller *M* value means higher stability. The control group, ethanol, hydrogen peroxide, acetaminophen, and carbon tetrachloride were abbreviated to WT, EtOH, H~2~O~2~, APAP, and CCl~4~, respectively.](BMRI2020-8926120.002){#fig2}

![Calculation of the optimal number of reference genes for quantitative analysis using geNorm. Pairwise variation (Vn/*n* + 1) of reference genes analyzed in different treatments was listed in (a, b) set the cut-off threshold value 0.15, calculating the optimal number of reference genes for precise quantitative in this work. WT, E100 (E200, E400), H100 (H200, H400, H800), A2.5 (A5, A10), and C0.05% (C0.1%, C0.2%, C0.4%), respectively, were the abbreviation for the control group, EtOH-100 mM (200 mM, 400 mM), H~2~O~2~-100 *μ*M (200 *μ*M, 400 *μ*M, 800 *μ*M), APAP-2.5 mM (5 mM, 10 mM, 20 mM), CCl~4~-0.05% (0.1%, 0.2%, 0.4%).](BMRI2020-8926120.003){#fig3}

###### 

Details of the ten candidate reference genes and primers used in the qPCR.

  --------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene     Description                                                                   Primer: forward/reverse(5′-3′)   Length (bp)   Accession number
  -------- ----------------------------------------------------------------------------- -------------------------------- ------------- ------------------
  ACTB     *β*-Actin                                                                     F: AAGGCCAACCGCGAGAAGAT\         102           NM_001101
                                                                                         R: GCCAGAGGCGTACAGGGATA                        

  B2M      Beta-2 microglobulin                                                          F: GTTTACTCACGTCATCCAGC\         141           NM_004048
                                                                                         R:AGACAAGTCTGAATGCTCCA                         

  GAPDH    Glyceraldehade-3-phosphate dehydrogenase                                      F: GCCTCCTGCACCACCAACTG\         149           NM_002046
                                                                                         R: CCATCACGCCACAGTTTCCC                        

  TUBB2a   Tubulin beta 2a                                                               F: AACGCCACCCTCTCTGTCCA\         143           NM_001069
                                                                                         R: GCCGACACCAGGTGGTTGAG                        

  HPRT1    Hypoxanthine phosphoribosyltransferase 1                                      F: ACTGAACGTCTTGCTCGAGA\         112           NM_000194
                                                                                         R: TGATGTAATCCAGCAGGTCA                        

  SDHA     Succinate dehydrogenase complex flavoprotein subunit A                        F: AAAGATCACGTCTACCTGCA\         150           NM_004168
                                                                                         R: CATGTTATAATGCACGGTGG                        

  TBP      TATA-box binding protein                                                      F: GTTCAGCAGTCAACGTCCCA\         127           NM_003194
                                                                                         R: TCATGGGGGAGGGATACAGT                        

  YWHAZ    Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta   F: CAGGCTGAGCGATATGATGA\         126           NM_003406
                                                                                         R: CCTACGGGCTCCTACAACAT                        

  CYC1     Cytochrome c isoform 1                                                        F: CCAAAACCATACCCCAACAG\         103           NM_001916
                                                                                         R: AGTCCTCACCACCATGCCTA                        

  GUSB     Glucuronidase beta                                                            F: GTTCCTTTTGCGAGAGAGAT\         124           NM_000181
                                                                                         R: ACACGCAGGTGGTATCAGTC                        
  --------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Expression stability values of ten candidate reference genes in HepG2 analyzed by NormFinder.

  ----------------------------------------------------------------------------------------------------------------------------------------------
  Rank   WT        EtOH\     EtOH\     EtOH\     H~2~O~2~\   H~2~O~2~\   H~2~O~2~\   APAP\     APAP\     APAP\     CCl~4~\   CCl~4~\   CCl~4~\
                   100 mM    200 mM    400 mM    200 *μ*M    400 *μ*M    800 *μ*M    2.5 mM    5 mM      10 mM     0.1%      0.2%      0.4%
  ------ --------- --------- --------- --------- ----------- ----------- ----------- --------- --------- --------- --------- --------- ---------
  1      HPRT1\    HPRT1\    CYC1\     HPRT1\    B2M\        CYC1\       TBP\        HPRT1\    GUSB\     HPRT1\    TBP\      TBP\      HPRT1\
         0.011     0.004     0.007     0.008     0.018       0.013       0.011       0.013     0.004     0.012     0.015     0.011     0.005

  2      TUBB2a\   TBP\      TBP\      TUBB2a\   TUBB2a\     TUBB2a\     GAPDH\      GUSB\     CYC1\     B2M\      CYC1\     ACTB\     CYC1\
         0.012     0.005     0.009     0.013     0.019       0.017       0.011       0.015     0.010     0.018     0.017     0.013     0.008

  3      CYC1\     TUBB2a\   SDHA\     B2M\      CYC1\       TBP\        SDHA\       SDHA\     TUBB2a\   SDHA\     SDHA\     B2M\      GUSB\
         0.013     0.005     0.011     0.014     0.020       0.019       0.012       0.018     0.014     0.019     0.020     0.021     0.009

  4      B2M\      YWHAZ\    B2M\      TBP\      TBP\        HPRT1\      HPRT1\      YWHAZ\    ACTB\     TUBB2a\   HPRT1\    TUBB2a\   TUBB2a\
         0.017     0.012     0.011     0.016     0.027       0.024       0.015       0.022     0.020     0.020     0.021     0.021     0.016

  5      TBP\      SDHA\     HPRT1\    SDHA\     GUSB\       GUSB\       B2M\        CYC1\     HPRT1\    CYC1\     TUBB2a\   CYC1\     SDHA\
         0.018     0.013     0.013     0.018     0.030       0.025       0.017       0.023     0.021     0.022     0.024     0.021     0.019

  6      SDHA\     ACTB\     GAPDH\    CYC1\     SDHA\       YWHAZ\      TUBB2a\     TBP\      TBP\      ACTB\     GUSB\     GUSB\     TBP\
         0.019     0.014     0.015     0.020     0.030       0.027       0.017       0.024     0.022     0.024     0.024     0.022     0.024

  7      ACTB\     CYC1\     GUSB\     ACTB\     YWHAZ\      ACTB\       CYC1\       ACTB\     YWHAZ\    GUSB\     YWHAZ\    YWHAZ\    B2M\
         0.020     0.022     0.015     0.025     0.037       0.031       0.017       0.028     0.025     0.025     0.028     0.022     0.029

  8      GUSB\     B2M\      TUBB2a\   GUSB\     ACTB\       B2M\        ACTB\       GAPDH\    B2M\      TBP\      GAPDH\    SDHA\     GAPDH\
         0.021     0.032     0.016     0.027     0.039       0.037       0.019       0.029     0.029     0.029     0.032     0.024     0.031

  9      YWHAZ\    GAPDH\    ACTB\     YWHAZ\    HPRT1\      SDHA\       GUSB\       TUBB2a\   SDHA\     GAPDH\    B2M\      HPRT1\    ACTB\
         0.023     0.041     0.020     0.028     0.046       0.043       0.022       0.030     0.031     0.035     0.034     0.029     0.037

  10     GAPDH\    GUSB\     YWHAZ\    GAPDH\    GAPDH\      GAPDH\      YWHAZ\      B2M\      GAPDH\    YWHAZ\    ACTB\     GAPDH\    YWHAZ\
         0.029     0.042     0.023     0.041     0.061       0.048       0.024       0.032     0.039     0.037     0.037     0.044     0.039
  ----------------------------------------------------------------------------------------------------------------------------------------------

###### 

Expression stability values of the reference genes calculated by BestKeeper in HepG2.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Rank   WT            EtOH\         EtOH\         EtOH\         H~2~O~2~\     H~2~O~2~\     H~2~O~2~\     APAP\         APAP\         APAP\         CCl~4~\       CCl~4~\       CCl~4~\
                       100 mM        200 mM        400 mM        200 *μ*M      400 *μ*M      800 *μ*M      2.5 mM        5 mM          10 mM         0.1%          0.2%          0.4%
  ------ ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------
  1      GUSB\         HPRT1\        SDHA\         B2M\          CYC1\         CYC1\         TBP\          SDHA\         CYC1\         GUSB\         GUSB\         HPRT1\        TBP\
         1.57 ± 0.45   1.10 ± 0.24   0.74 ± 0.20   1.57 ± 0.29   1.37 ± 0.33   1.49 ± 0.36   0.85 ± 0.24   1.78 ± 0.44   0.95 ± 0.25   1.75 ± 0.59   0.90 ± 0.26   1.67 ± 0.38   1.15 ± 0.30

  2      ACTB\         CYC1\         TBP\          TBP\          TUBB2a\       YWHAZ\        CYC1\         TBP\          GUSB\         CYC1\         CYC1\         GUSB\         SDHA\
         1.89 ± 0.39   1.24 ± 0.3    1.00 ± 0.26   1.67 ± 0.44   1.68 ± 0.48   1.51 ± 0.35   0.95 ± 0.24   2.50 ± 0.63   1.47 ± 0.46   2.60 ± 0.75   1.10 ± 0.27   1.68 ± 0.51   1.53 ± 0.38

  3      TUBB2a\       TBP\          CYC1\         SDHA\         SDHA\         GUSB\         B2M\          TUBB2a\       TUBB2a\       TUBB2a\       HPRT1\        TBP\          CYC1\
         2.22 ± 0.63   1.28 ± 0.33   1.08 ± 0.27   1.70 ± 0.46   1.90 ± 0.51   1.54 ± 0.47   1.08 ± 0.21   2.83 ± 0.72   1.59 ± 0.45   3.25 ± 0.94   1.43 ± 0.32   1.72 ± 0.45   1.72 ± 0.43

  4      CYC1\         SDHA\         GUSB\         YWHAZ\        TBP\          HPRT1\        SDHA\         GUSB\         HPRT1\        ACTB\         B2M\          CYC1\         TUBB2a\
         2.41 ± 0.57   1.79 ± 0.47   1.12 ± 0.34   2.08 ± 0.47   2.28 ± 0.61   1.77 ± 0.40   1.16 ± 0.32   2.97 ± 0.86   1.64 ± 0.41   3.27 ± 0.77   1.99 ± 0.37   1.84 ± 0.47   1.97 ± 0.54

  5      B2M\          TUBB2a\       ACTB\         HPRT1\        ACTB\         TUBB2a\       HPRT1\        YWHAZ\        B2M\          TBP\          TBP\          YWHAZ\        HPRT1\
         2.65 ± 0.48   1.92 ± 0.54   1.16 ± 0.25   2.12 ± 0.49   2.58 ± 0.53   1.80 ± 0.52   1.22 ± 0.29   3.25 ± 0.71   1.74 ± 0.35   3.38 ± 0.98   2.19 ± 0.57   2.40 ± 0.54   2.31 ± 0.53

  6      TBP\          ACTB\         B2M\          CYC1\         B2M\          TBP\          GAPDH\        HPRT1\        YWHAZ\        B2M\          SDHA\         TUBB2a\       GUSB\
         2.78 ± 0.72   2.01 ± 0.41   1.19 ± 0.22   2.16 ± 0.53   2.84 ± 0.51   1.84 ± 0.49   1.39 ± 0.25   3.28 ± 0.76   2.17 ± 0.53   3.90 ± 0.88   2.42 ± 0.61   2.58 ± 0.73   2.72 ± 0.81

  7      HPRT1\        YWHAZ\        TUBB2a\       TUBB2a\       GUSB\         ACTB\         GUSB\         CYC1\         ACTB\         HPRT1\        YWHAZ\        ACTB\         YWHAZ\
         3.10 ± 0.70   2.13 ± 0.47   1.28 ± 0.37   2.20 ± 0.62   2.96 ± 0.88   2.78 ± 0.57   1.59 ± 0.50   3.31 ± 0.82   2.20 ± 0.50   4.04 ± 1.11   2.45 ± 0.54   2.84 ± 0.57   2.97 ± 0.67

  8      SDHA\         GUSB\         GAPDH\        GUSB\         YWHAZ\        B2M\          TUBB2a\       ACTB\         TBP\          SDHA\         TUBB2a\       B2M\          ACTB\
         3.41 ± 0.91   2.18 ± 0.65   1.45 ± 0.25   2.58 ± 0.78   3.48 ± 0.78   3.14 ± 0.59   1.62 ± 0.47   3.39 ± 0.67   2.59 ± 0.72   4.41 ± 1.30   2.63 ± 0.74   2.92 ± 0.55   3.92 ± 0.75

  9      YWHAZ\        B2M\          HPRT1\        ACTB\         HPRT1\        SDHA\         ACTB\         B2M\          SDHA\         GAPDH\        ACTB\         SDHA\         B2M\
         3.63 ± 0.82   2.82 ± 0.51   1.55 ± 0.35   3.37 ± 0.71   4.86 ± 1.10   3.84 ± 1.05   1.65 ± 0.36   4.86 ± 0.92   2.68 ± 0.73   4.81 ± 0.97   2.95 ± 0.60   3.32 ± 0.84   4.41 ± 0.83

  10     GAPDH\        GAPDH\        YWHAZ\        GAPDH\        GAPDH\        GAPDH\        YWHAZ\        GAPDH\        GAPDH\        YWHAZ\        GAPDH\        GAPDH\        GAPDH\
         3.99 ± 0.66   3.30 ± 0.55   2.32 ± 0.54   4.03 ± 0.71   5.26 ± 0.89   4.21 ± 0.71   2.24 ± 0.53   4.95 ± 0.78   3.43 ± 0.63   6.38 ± 1.64   3.42 ± 0.57   4.38 ± 0.73   4.46 ± 0.73
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[^1]: Academic Editor: Sercan Ergün
